Loading…
← CockpitCompetitor Analysis › 2192.HK Medlive Technology Co., Ltd.Open in the cockpit ↗

Medlive Technology Co., Ltd.2192.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Industrials›Miscellaneous Commercial Services
Momentum neutral 43
Mkt cap
$621M
US dollars, full cap
Free float
26%
of shares outstanding
$/day
$597,974
20-day average traded
Fwd P/E
12.6×
forward earnings
ROIC−WACC
-4.7 pp
WACC 11.4%
Hurdle
-24 pp
Req g minus delivered
Next earnings
143 days
29 Mar 2027
Close · HKDHK$6.58
1D-0.6%
1W+4.4%
1M+2.4%
3M-15.2%
6M-25.5%
YTD-32.2%
1Y-39.9%
ATR %4.3%
52w lowhigh56.2% off high

What Medlive Technology does

Employees: 724

Medlive Technology at a glance

Size Medlive Technology (2192.HK) is a Hong Kong Industrials company (Miscellaneous Commercial Services) with a market value of $621M, the 705th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$6.58 on 6 Nov 2026.

Performance Over six months the shares fell 25.5%, against -17.2% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — 8th lowest of 21 in its peer set.

Growth Revenue grew 6.5% over the last twelve months (peer median +2.2%); the operating margin is 28.9% (peer median 7.9%).

Valuation It trades at 12.6× forward earnings against a peer median of 14.9× (3rd cheapest of 11).

Price implies For today's price to make sense, revenue must grow about 0% a year for seven years (Req g). Recent delivered growth is +24%, so the hurdle is -24 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 4.7 points below its cost of capital (11.4% WACC).

Next results Next results expected around 29 Mar 2027 (exchange calendar; dates can move).

Relative performance

70809010011 May 202611 Aug 20266 Nov 2026Peer median 822192.HK 73
Six months, rebased to 100: Medlive Technology against the median of its 20 peers (local-currency closes).

Medlive Technology financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$721MHK$696MHK$605MHK$455MHK$365M
Revenue growth—+15%+33%+25%—
Gross profitHK$424MHK$401MHK$342MHK$270MHK$239M
EBITDAHK$239MHK$206MHK$145MHK$99.7MHK$81.9M
Net incomeHK$380MHK$363MHK$342MHK$268MHK$136M
Free cash flowHK$307MHK$333MHK$283MHK$281MHK$139M
Capital expenditureHK$2.87MHK$13.9MHK$22.6MHK$35.9MHK$8.71M
Total debtn/aHK$11.3MHK$24.1MHK$9.02MHK$12.6M

Quarterly statements and history in the cockpit →

Medlive Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%0%301468229161962874603018300071300355FRAMERY61833002154071603060301446INTRUM30014932653625300916301365IBEX2192.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Medlive Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%20×40×60×301468229161962874603018FRAMERY61834071603060IBEX2192.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Medlive Technology is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%2291603018300071300355FRAMERY61833002154071603060INTRUM300149301365IBEX2192.HKGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Medlive Technology is the large dot.

Medlive Technology competitors and peer comparison

How Medlive Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Medlive Technology against its 20 peers (data as of 6 Nov 2026)
Measure2192.HKPeer medianRank in peer set
1-month return+2.4%-4.6%9th highest of 21
6-month return-25.5%-17.2%8th lowest of 21
Distance from 52-week high-56.2%-38.9%5th lowest of 21
Revenue growth (TTM)+6.5%+2.2%10th highest of 21
Operating margin28.9%7.9%4th highest of 21
Forward P/E12.6×14.9×3rd cheapest of 11
Growth the price implies (Req g, 7 yrs)-0.3%5.9%5th least demanding of 14
Growth delivered (Del g)+23.8%+1.4%3rd highest of 14
Hurdle (Req g minus delivered)-24.1 pp-2.9 pp3rd least demanding of 14
ROIC minus cost of capital-4.7 pp+0.1 pp5th lowest of 19
EV / EBITDA7.8×9.7×3rd cheapest of 9
Net debt / EBITDA-12.8×1.2×least indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Medlive Technology 2192.HKHong Kong$621M-25%+6%29%12.6×-0.3%+23.8%
Pourin Special Welding Technology 301468.SZChina$621M-40%-4%5%66.1×n/an/a
LEPU ScienTech Medical Technology (Shanghai) 2291.HKHong Kong$624M+25%-4%42%11.8×-8.4%+28.0%
Strike 6196.TJapan$618M+29%+33%38%14.4×n/an/a
Yokorei 2874.TJapan$617M0%+1%5%15.1×n/an/a
China Design 603018.SSChina$616M-20%-8%7%15.5×-8.0%-5.1%
FS Development Investment 300071.SZChina$612M-13%-41%-18%n/a34.6%+1.0%
M-Grass Ecology And Environment (Group) 300355.SZChina$611M-30%-23%-13%n/a11.6%+0.5%
Framery FRAMERY.HEFinland$632M0%+37%20%14.7×5.9%+13.4%
BELLSYSTEM24 6183.TJapan$637M-10%+1%8%11.3×-5.7%+1.4%
Suzhou Electrical Apparatus Science Academy 300215.SZChina$605M-36%+8%9%n/a8.1%-4.9%
Plus Alpha Consulting 4071.TJapan$602M+3%+13%39%17.9×2.9%+29.3%
China Testing & Certification International 603060.SSChina$602M-25%-6%4%31.2×12.0%+12.1%
Jiangxi First Hydraulic 301446.SZChina$601M-5%+33%10%n/an/an/a
Intrum INTRUM.STSweden$645M-53%-4%28%n/a-8.9%+0.2%
ChemPartner PharmaTech 300149.SZChina$645M-14%+18%2%n/a25.6%-5.2%
Winstek Semiconductor 3265.TWOTaiwan$593M-24%+15%20%n/an/an/a
Shanghai FourSemi Semiconductor 3625.HKHong Kong$592M-69%+3%-16%n/an/an/a
Shenzhen Longtech Smart Control 300916.SZChina$589M-27%-2%3%n/an/an/a
Matrix Design 301365.SZChina$660M-31%+9%4%n/a29.3%+3.6%
IBEX IBEXUnited States$661M+53%+15%9%13.1×0.3%+7.7%

Questions

Which companies are Medlive Technology's closest peers?
The cockpit's peer set: Pourin Special Welding Technology (301468.SZ), LEPU ScienTech Medical Technology (Shanghai) (2291.HK), Strike (6196.T), Yokorei (2874.T), China Design (603018.SS), FS Development Investment (300071.SZ), M-Grass Ecology And Environment (Group) (300355.SZ), Framery (FRAMERY.HE).
Is Medlive Technology expensive compared with its peers?
On forward p/e it trades at 12.6× against a peer median of 14.9×, 3rd cheapest of 11 in its peer set. For today's price to make sense, revenue must grow about 0% a year for seven years (Req g). Recent delivered growth is +24%, so the hurdle is -24 pp: the price already allows for a slowdown.
How has Medlive Technology stock performed?
Over six months to 6 Nov 2026 the shares returned -25.5% against -17.2% for the median peer; over one year -39.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.